Basket | Login | Register

 
 
 
 

Clinical trials by country

Phase II trials

Austria

  1. LM11A-31-BHS

Czech Republic

  1. LM11A-31-BHS

Finland

  1. ACI-24-1801
  2. MAPT-CS1

France

  1. ABvac40
  2. ETHERAL
  3. LAURIET
  4. TANGO

Germany

  1. LM11A-31-BHS
  2. MAPT-CS1
  3. TANGO

Italy

  1. ABvac40
  2. TANGO

Netherlands

  1. MAPT-CS1

Poland

  1. ACI-24-1801 (planned)
  2. LAURIET
  3. TANGO

Spain

  1. ABvac40
  2. ETHERAL
  3. LAURIET
  4. LM11A-31-BHS
  5. TANGO

Sweden

  1. ABvac40
  2. ACI-24-1801
  3. LM11A-31-BHS
  4. MAPT-CS1
  5. TANGO
  6. VALZ-Pilot

UK

  1. ACI-24-1801
  2. DESPIAD
  3. ETHERAL
  4. MAPT-CS1

 

 
 

Last Updated: Thursday 08 August 2019

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options